Goldstein DA - Search Results

1

Adjuvant therapy for pancreas cancer in an era of value based cancer care.

Ahn DH, Williams TM, Goldstein DA, El-Rayes B, Bekaii-Saab T. Ahn DH, et al. Among authors: goldstein da. Cancer Treat Rev. 2016 Jan;42:10-7. doi: 10.1016/j.ctrv.2015.11.004. Epub 2015 Nov 24. Cancer Treat Rev. 2016. PMID: 26620819 Free PMC article. Review.

2

Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in FOLFOX chemotherapy for metastatic colorectal cancer.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, Harvey RD, El-Rayes BF, Flowers CR. Goldstein DA, et al. Clin Colorectal Cancer. 2014 Dec;13(4):219-25. doi: 10.1016/j.clcc.2014.09.007. Epub 2014 Sep 21. Clin Colorectal Cancer. 2014. PMID: 25306485

3

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR. Goldstein DA, et al. J Clin Oncol. 2015 Apr 1;33(10):1112-8. doi: 10.1200/JCO.2014.58.4904. Epub 2015 Feb 17. J Clin Oncol. 2015. PMID: 25691669 Free PMC article.

4

Considering Efficacy and Cost, Where Does Ramucirumab Fit in the Management of Metastatic Colorectal Cancer?

Goldstein DA, El-Rayes BF. Goldstein DA, et al. Oncologist. 2015 Sep;20(9):981-2. doi: 10.1634/theoncologist.2015-0028. Epub 2015 Aug 11. Oncologist. 2015. PMID: 26265225 Free PMC article.

5

Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al.

Goldstein DA, El-Rayes BF, Chen Q, Flowers CR. Goldstein DA, et al. J Clin Oncol. 2015 Nov 10;33(32):3842-3. doi: 10.1200/JCO.2015.62.9279. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304876 No abstract available.

6

Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer.

Goldstein DA, Ahmad BB, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR. Goldstein DA, et al. J Clin Oncol. 2015 Nov 10;33(32):3727-32. doi: 10.1200/JCO.2015.61.9569. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304904 Free PMC article.

7

Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies.

Goldstein DA, Zeichner SB, Bartnik CM, Neustadter E, Flowers CR. Goldstein DA, et al. Clin Colorectal Cancer. 2016 Mar;15(1):1-6. doi: 10.1016/j.clcc.2015.10.002. Epub 2015 Oct 22. Clin Colorectal Cancer. 2016. PMID: 26541320 Free PMC article. Review.

8

Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience.

Bupathi M, Ahn DH, Wu C, Ciombor KK, Stephens JA, Reardon J, Goldstein DA, Bekaii-Saab T. Bupathi M, et al. Among authors: goldstein da. Med Oncol. 2016 Apr;33(4):37. doi: 10.1007/s12032-016-0753-9. Epub 2016 Mar 19. Med Oncol. 2016. PMID: 26995224 Free PMC article. Clinical Trial.

9

Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer.

Goldstein DA, Krishna K, Flowers CR, El-Rayes BF, Bekaii-Saab T, Noonan AM. Goldstein DA, et al. Med Oncol. 2016 May;33(5):48. doi: 10.1007/s12032-016-0762-8. Epub 2016 Apr 11. Med Oncol. 2016. PMID: 27067436

10

Understanding the value of cancer drugs-the devil is in the detail.

Goldstein DA. Goldstein DA. Cancer. 2016 Aug 1;122(15):2292-5. doi: 10.1002/cncr.30044. Epub 2016 May 10. Cancer. 2016. PMID: 27163796 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters